Tau Phosphorylation in Female Neurodegeneration: Role of Estrogens, Progesterone, and Prolactin


Por: Munoz-Mayorga, Daniel, Guerra-Araiza, Christian, Torner, Luz, Morales, Teresa

Publicada: 28 mar 2018
Categoría: Endocrinology, diabetes and metabolism

Resumen:
Sex differences are important to consider when studying different psychiatric, neuro-developmental, and neurodegenerative disorders, including Alzheimer's disease (AD). These disorders can be affected by dimorphic changes in the central nervous system and be influenced by sex-specific hormones and neuroactive steroids. In fact, AD is more prevalent in women than in men. One of the main characteristics of AD is the formation of neurofibrillary tangles, composed of the phosphoprotein Tau, and neuronal loss in specific brain regions. The scope of this work is to review the existing evidence on how a set of hormones (estrogen, progesterone, and prolactin) affect tau phosphorylation in the brain of females under both physiological and pathological conditions.

Filiaciones:
Munoz-Mayorga, Daniel:
 Univ Nacl Autonoma Mexico, Inst Neurobiol, Dept Neurobiol Celular & Mol, Queretaro, Mexico

Guerra-Araiza, Christian:
 Hosp Especialidades Ctr Med La Raza, Inst Mexicano Seguro Social, Ctr Med Nacl Siglo 21, Unidad Invest Med Farmacol, Mexico City, DF, Mexico

Torner, Luz:
 Inst Mexicano Seguro Social, Ctr Invest Biomed Michoacan, Morelia, Michoacan, Mexico

Morales, Teresa:
 Univ Nacl Autonoma Mexico, Inst Neurobiol, Dept Neurobiol Celular & Mol, Queretaro, Mexico
ISSN: 16642392
Editorial
Frontiers Research Foundation, PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND, Suiza
Tipo de documento: Review
Volumen: 9 Número: MAR
Páginas:
WOS Id: 000428529100002
ID de PubMed: 29643836